Letter: high oral dose of taurine for portal hypertension in cirrhotic patients—some clinical pharmacology considerations

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2036|47|6|861-862

ISSN： 0269-2813

Source： ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol.47, Iss.6, 2018-03, pp. : 861-862

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Editorial: getting bullish about portal hypertension—chronic treatment with oral taurine?

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 47, Iss. 4, 2018-02 ,pp. : 533-534

John Wiley & Sons Inc

Access to resources Recommend Favorite

Evaluation of portal hypertension by real‐time shear wave elastography in cirrhotic patients

By  

LIVER INTERNATIONAL (ELECTRONIC), Vol. 35, Iss. 11, 2015-11 ,pp. : 2416-2424

John Wiley & Sons Inc

Access to resources Recommend Favorite

Editorial: getting bullish about portal hypertension—chronic treatment with oral taurine? Author's reply

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 47, Iss. 4, 2018-02 ,pp. : 534-535

John Wiley & Sons Inc

Access to resources Recommend Favorite

Letter: nutritional benefits of rifaximin in cirrhotic patients

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 47, Iss. 5, 2018-03 ,pp. : 699-700

John Wiley & Sons Inc

Access to resources Recommend Favorite

Hepatopulmonary Syndrome in children: a comparative study of non‐cirrhotic vs. cirrhotic portal hypertension

By  

LIVER INTERNATIONAL (ELECTRONIC), Vol. 35, Iss. 6, 2015-06 ,pp. : 1665-1672

John Wiley & Sons Inc

Access to resources Recommend Favorite